Vaccinium Extracts as Modulators in Experimental Type 1 Diabetes

Area of Science:

• Pharmacology and Toxicology
• Diabetology
• Natural Product Research

Background:

• Diabetes mellitus is a metabolic disorder characterized by hyperglycemia and associated complications.
• Diabetic complications, including cataracts and oxidative stress, significantly impact patient quality of life.
• Natural products are increasingly investigated for their therapeutic potential in managing diabetes and its sequelae.

Purpose of the Study:

• To evaluate the antihyperglycemic effects of Vaccinium myrtillus and Vaccinium corymbosum extracts in a rat model of type 1 diabetes.
• To assess the impact of these extracts on diabetic complications, specifically cataract development and oxidative stress.
• To compare the efficacy of leaf and fruit extracts from both species.

Main Methods:

• Type 1 diabetes was induced in Wistar rats using streptozotocin.
• Rats were treated with metformin (positive control), V. myrtillus leaf/fruit extracts, or V. corymbosum leaf/fruit extracts for 8 weeks.
• Body weight, serum glucose, insulin, and malondialdehyde levels were measured. Cataract development was evaluated in isolated lenses.

Main Results:

• V. myrtillus leaf extract (VML) and combined V. myrtillus extracts (VMLF) significantly reduced blood glucose levels.
• V. myrtillus extracts (VML and VMLF) prevented the development of diabetic cataracts compared to the diabetic control group.
• V. corymbosum leaf extract (VCL) showed limited antihyperglycemic effect, while VCLF's efficacy was not clearly differentiated.

Conclusions:

• Vaccinium myrtillus extracts possess significant antihyperglycemic properties and protective effects against diabetic cataract formation.
• Further research into V. myrtillus constituents may yield novel therapeutic strategies for diabetes management.
• Vaccinium corymbosum extracts demonstrated less potent effects in this diabetic rat model.